Organ Preservation Market to Reach USD 7.12 Billion by 2032 at 12.6% CAGR | North America Leads with 39% Share | Key Players XVIVO Perfusion, BioLife Solutions, CryoLife

Organ Preservation Market reached USD 2.24 billion in 2024 and is expected to reach USD 7.12 billion by 2032, growing at a CAGR of 12.6% during the forecast period 2025-2032.

The organ preservation market is being driven by the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and renal failure, which have increased the demand for organ transplants globally. Technological advancements in preservation solutions, organ transport systems, and hypothermic and normothermic perfusion techniques are significantly enhancing the viability and longevity of organs outside the human body, thereby improving transplant success rates and patient outcomes.

Growing investments in research and development, increasing number of transplant procedures, and expanding healthcare infrastructure in emerging markets are further propelling market growth. Additionally, ongoing innovations in bioengineering and cryopreservation technologies, along with supportive regulatory frameworks and partnerships among healthcare providers, research institutions, and biotech companies, are expected to sustain robust demand and advance the global organ preservation landscape throughout the forecast period

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/organ-preservation-market?sai-v

The Organ Preservation Market refers to the global industry focused on the development and use of technologies, solutions, and services that maintain the viability and function of organs outside the body prior to transplantation, including cold storage solutions, perfusion systems, and preservation fluids.

Key Developments
✅ January 2026: In Japan, advancements in hypothermic and normothermic organ preservation technologies improved transplant success rates by extending viable storage time and enhancing real-time organ viability assessment prior to transplantation.

✅ January 2026: Across the United States and Canada, increasing adoption of machine perfusion systems and preservation solutions supported higher utilization of donor organs, reduced ischemic injury, and improved post-transplant patient outcomes across kidney, liver, and heart transplants.

✅ January 2026: In Europe, regulatory support and clinical research expansion accelerated deployment of advanced preservation platforms, including portable perfusion devices and oxygenated preservation techniques for multi-organ transplantation.

✅ December 2025: Across Asia-Pacific markets outside Japan, rising transplant volumes and healthcare infrastructure investments encouraged procurement of modern preservation equipment and temperature-controlled transport systems to improve organ logistics and surgical readiness.

✅ December 2025: Globally, integration of biomarker monitoring, AI-assisted viability prediction, and next-generation preservation fluids enhanced organ assessment accuracy and optimized transplant decision-making processes.

✅ November 2025: In Latin America, expansion of transplant programs and public awareness initiatives increased demand for reliable cold storage solutions, perfusion devices, and specialized preservation reagents.

✅ October 2025: Worldwide, growing focus on reducing organ discard rates and improving long-distance transport feasibility accelerated innovation in portable preservation technologies and regenerative preservation approaches.

Mergers & Acquisitions
✅ January 2026: A global transplant technology company acquired a developer of normothermic machine perfusion systems to strengthen its advanced organ preservation portfolio and expand clinical adoption.

✅ December 2025: A multinational medical device manufacturer acquired a preservation solution formulation firm to enhance product offerings for multi-organ storage and transport.

✅ November 2025: A biotechnology company acquired a startup specializing in organ viability monitoring sensors to improve real-time transplant assessment and preservation outcomes.

Key Players
CryoLife, Inc. | Lifeline Scientific | BioTime, Inc. | Claris Lifesciences Limited | BioLife Solutions, Inc. | Dr. Franz Köhler Chemie GmbH | Bristol-Myers Squibb | Tolerotech, Inc. | 21st Century Medicine | XVIVO Perfusion AB | Others

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=organ-preservation-market?sai-v

(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

Market Drivers
- Rising prevalence of organ failure and increasing number of transplant procedures worldwide are significantly driving demand for advanced organ preservation solutions.

- Growing shortage of donor organs and the need to extend organ viability during transportation are encouraging adoption of innovative preservation technologies and solutions.

- Advancements in hypothermic and normothermic machine perfusion techniques are improving transplant success rates and expanding the usable donor organ pool.

- Supportive government initiatives, transplant awareness programs, and improvements in healthcare infrastructure are further strengthening market growth.

Industry Developments
- Development of next-generation preservation solutions, portable perfusion devices, and temperature-controlled transport systems enhancing organ viability and safety.

- Increasing clinical adoption of machine perfusion technologies for kidney, liver, heart, and lung transplantation to improve post-transplant outcomes.

- Strategic collaborations between biotechnology firms, medical device manufacturers, and transplant centers to accelerate research and commercialization.

- Expansion of clinical trials and regulatory approvals for advanced preservation methods supporting broader global adoption.

- Growing investment in biobanking, regenerative medicine, and organ repair technologies to extend preservation duration and transplant success.

Regional Insights
North America - Holds 39% share: Driven by advanced transplant infrastructure, high healthcare spending, and strong presence of leading medical device companies.

Europe - Holds 30% share: Supported by established organ donation programs, favorable reimbursement systems, and ongoing research in transplant technologies.

Asia Pacific - Holds 22% share: Fueled by improving healthcare access, rising transplant procedures, and increasing government focus on organ donation awareness.

Latin America - Holds 5% share: Growth supported by expanding transplant capabilities and gradual improvements in healthcare infrastructure.

Middle East & Africa - Holds 4% share: Expansion driven by increasing healthcare investments, developing transplant programs, and rising awareness of organ donation.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/organ-preservation-market?sai-v

Key Segments

By Technique
Static cold storage (SCS) holds a dominant share due to its widespread clinical adoption, cost-effectiveness, and established reliability in short-term organ preservation. Hypothermic perfusion preservation represents a significant segment, supported by its ability to extend preservation time, improve organ viability, and enhance transplant outcomes. Normothermic machine perfusion is gaining rapid traction as it enables real-time functional assessment, reduced ischemic injury, and improved utilization of marginal donor organs. Other emerging techniques continue to advance preservation efficiency and transplant success rates.

By Preservation Solution
University of Wisconsin (UW) solution accounts for a major share owing to its long-standing clinical use and proven effectiveness in preserving abdominal organs. Custodiol HTK and Perfadex solutions represent important segments, widely used for heart and lung preservation due to their protective biochemical properties. Collins and citrate-based solutions contribute to specific preservation needs across transplant procedures. Other specialized preservation solutions are being developed to enhance organ viability, reduce cellular damage, and support extended storage durations.

By Organ Type
Kidneys represent the largest segment due to the high volume of kidney transplant procedures worldwide and increasing prevalence of renal failure. Liver, lung, and heart transplants also account for significant shares, driven by rising incidence of chronic diseases and advancements in transplant technology. Other organs, including pancreas and intestine, contribute to market growth through specialized transplant procedures and ongoing improvements in surgical and preservation techniques.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.